Leon M. Ptaszek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 10 | 2021 | 5034 | 0.800 |
Why?
|
| Heart Conduction System | 3 | 2017 | 1047 | 0.740 |
Why?
|
| Methacrylates | 1 | 2020 | 107 | 0.720 |
Why?
|
| Tissue Adhesives | 1 | 2020 | 179 | 0.650 |
Why?
|
| Gelatin | 1 | 2020 | 225 | 0.650 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2017 | 493 | 0.630 |
Why?
|
| Electric Countershock | 2 | 2019 | 534 | 0.620 |
Why?
|
| Software Design | 1 | 2017 | 176 | 0.600 |
Why?
|
| Ventricular Premature Complexes | 1 | 2017 | 111 | 0.570 |
Why?
|
| Critical Pathways | 2 | 2019 | 476 | 0.550 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 789 | 0.510 |
Why?
|
| Length of Stay | 3 | 2019 | 6309 | 0.500 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 240 | 0.440 |
Why?
|
| Electrodes, Implanted | 2 | 2014 | 824 | 0.400 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 238 | 0.390 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2017 | 1534 | 0.370 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 643 | 0.360 |
Why?
|
| Action Potentials | 1 | 2017 | 1806 | 0.360 |
Why?
|
| Myocardium | 2 | 2020 | 4776 | 0.340 |
Why?
|
| Patient Admission | 1 | 2016 | 1380 | 0.320 |
Why?
|
| Patient Care Team | 1 | 2019 | 2531 | 0.310 |
Why?
|
| Anticoagulants | 2 | 2021 | 4599 | 0.310 |
Why?
|
| Regeneration | 2 | 2013 | 1485 | 0.280 |
Why?
|
| Heart Rate | 1 | 2017 | 4091 | 0.280 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1294 | 0.280 |
Why?
|
| Disease Management | 1 | 2016 | 2459 | 0.260 |
Why?
|
| Myocardial Infarction | 5 | 2023 | 11727 | 0.260 |
Why?
|
| Hospitalization | 4 | 2022 | 10262 | 0.250 |
Why?
|
| Defibrillators, Implantable | 3 | 2015 | 1440 | 0.250 |
Why?
|
| DNA Mismatch Repair | 1 | 2007 | 426 | 0.250 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 7659 | 0.240 |
Why?
|
| Gene Targeting | 1 | 2007 | 880 | 0.240 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 1620 | 0.240 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 1224 | 0.230 |
Why?
|
| Hemochromatosis | 1 | 2005 | 184 | 0.230 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2023 | 45 | 0.220 |
Why?
|
| Genome | 2 | 2008 | 1808 | 0.210 |
Why?
|
| Atrial Appendage | 2 | 2021 | 283 | 0.210 |
Why?
|
| Image Enhancement | 1 | 2012 | 2921 | 0.200 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2023 | 125 | 0.200 |
Why?
|
| Chikungunya virus | 1 | 2021 | 50 | 0.200 |
Why?
|
| Pacemaker, Artificial | 3 | 2019 | 816 | 0.200 |
Why?
|
| Catheter Ablation | 4 | 2018 | 2758 | 0.200 |
Why?
|
| Pericardial Effusion | 2 | 2021 | 247 | 0.200 |
Why?
|
| Equipment Design | 4 | 2018 | 3582 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 1488 | 0.180 |
Why?
|
| Electrocardiography | 6 | 2019 | 6442 | 0.180 |
Why?
|
| Sus scrofa | 2 | 2018 | 437 | 0.170 |
Why?
|
| Drug Compounding | 1 | 2020 | 242 | 0.170 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 56 | 0.170 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1912 | 0.160 |
Why?
|
| Heart | 1 | 2012 | 4467 | 0.160 |
Why?
|
| Prosthesis Implantation | 2 | 2021 | 642 | 0.160 |
Why?
|
| Endocarditis, Bacterial | 1 | 2022 | 455 | 0.160 |
Why?
|
| Endocarditis | 1 | 2022 | 350 | 0.160 |
Why?
|
| Hydrogels | 2 | 2020 | 724 | 0.150 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 101 | 0.150 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 301 | 0.150 |
Why?
|
| Heart Ventricles | 3 | 2018 | 3821 | 0.150 |
Why?
|
| Troponin T | 1 | 2021 | 754 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 297 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2022 | 538 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2009 | 3110 | 0.140 |
Why?
|
| Lyme Disease | 1 | 2021 | 621 | 0.130 |
Why?
|
| Rest | 2 | 2017 | 901 | 0.130 |
Why?
|
| Pyridazines | 1 | 2017 | 202 | 0.130 |
Why?
|
| Tissue Engineering | 2 | 2018 | 1880 | 0.130 |
Why?
|
| Swine | 5 | 2018 | 5917 | 0.130 |
Why?
|
| Coronary Circulation | 2 | 2017 | 1572 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 1198 | 0.120 |
Why?
|
| Ventricular Fibrillation | 2 | 2023 | 538 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 868 | 0.120 |
Why?
|
| Bundle-Branch Block | 1 | 2015 | 270 | 0.110 |
Why?
|
| Fibrosis | 1 | 2020 | 2029 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 222 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1240 | 0.110 |
Why?
|
| Homeodomain Proteins | 5 | 2011 | 2421 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 767 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2021 | 13033 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2014 | 210 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 307 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 2 | 2015 | 1965 | 0.110 |
Why?
|
| Temperature | 1 | 2018 | 2206 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
| Animals | 19 | 2020 | 168757 | 0.100 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 554 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18029 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 956 | 0.100 |
Why?
|
| Cicatrix | 1 | 2017 | 764 | 0.100 |
Why?
|
| Heart Failure | 3 | 2015 | 10900 | 0.100 |
Why?
|
| VDJ Recombinases | 4 | 2003 | 84 | 0.100 |
Why?
|
| Warfarin | 1 | 2019 | 1496 | 0.100 |
Why?
|
| Lipids | 1 | 2021 | 3305 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1207 | 0.090 |
Why?
|
| Humans | 38 | 2023 | 744343 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 19905 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2022 | 77449 | 0.090 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1586 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 2 | 2009 | 1273 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2708 | 0.080 |
Why?
|
| Middle Aged | 15 | 2021 | 213383 | 0.080 |
Why?
|
| Cardiology | 1 | 2019 | 1668 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 391 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20129 | 0.080 |
Why?
|
| Stroke | 2 | 2021 | 9981 | 0.080 |
Why?
|
| DNA Nucleotidyltransferases | 3 | 2002 | 193 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3670 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 795 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1632 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 620 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 3537 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2021 | 15295 | 0.070 |
Why?
|
| Pericardium | 1 | 2011 | 667 | 0.070 |
Why?
|
| Esophageal Fistula | 1 | 2007 | 64 | 0.070 |
Why?
|
| Blastocyst | 1 | 2010 | 424 | 0.070 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2124 | 0.070 |
Why?
|
| Male | 20 | 2021 | 350118 | 0.070 |
Why?
|
| Angina Pectoris | 1 | 2011 | 977 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3313 | 0.070 |
Why?
|
| Aged | 11 | 2021 | 163280 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57776 | 0.070 |
Why?
|
| Biomedical Technology | 1 | 2008 | 220 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3107 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2020 | 3445 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15076 | 0.070 |
Why?
|
| Immunity | 1 | 2011 | 1012 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 53288 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.060 |
Why?
|
| Esophagus | 1 | 2011 | 1019 | 0.060 |
Why?
|
| Pulmonary Veins | 2 | 2010 | 761 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 1005 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2010 | 711 | 0.060 |
Why?
|
| Time Factors | 5 | 2021 | 40075 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2001 | 1179 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2010 | 859 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 6234 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 834 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2504 | 0.060 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 202 | 0.060 |
Why?
|
| Fibroma | 1 | 2006 | 212 | 0.060 |
Why?
|
| CpG Islands | 1 | 2008 | 1172 | 0.060 |
Why?
|
| Adult | 10 | 2021 | 214055 | 0.060 |
Why?
|
| Models, Molecular | 1 | 1994 | 5456 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 131 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1357 | 0.060 |
Why?
|
| DNA | 6 | 2010 | 7301 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 35421 | 0.060 |
Why?
|
| Female | 15 | 2021 | 380194 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1637 | 0.060 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2021 | 1206 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 18370 | 0.050 |
Why?
|
| Liver Failure | 1 | 2005 | 241 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5078 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 374 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 549 | 0.050 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.050 |
Why?
|
| California | 1 | 2005 | 1402 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1708 | 0.050 |
Why?
|
| Electronics | 1 | 2022 | 322 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 1541 | 0.050 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2021 | 124 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3567 | 0.050 |
Why?
|
| Wound Healing | 1 | 2011 | 2785 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2021 | 173 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14722 | 0.050 |
Why?
|
| Burns | 1 | 2011 | 1815 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1850 | 0.040 |
Why?
|
| Device Approval | 1 | 2021 | 163 | 0.040 |
Why?
|
| Sotalol | 1 | 2019 | 49 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2006 | 934 | 0.040 |
Why?
|
| Steam | 1 | 2018 | 31 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4577 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2021 | 578 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 187 | 0.040 |
Why?
|
| Ink | 1 | 2018 | 44 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2013 | 10252 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2014 | 23338 | 0.040 |
Why?
|
| Risk Factors | 5 | 2015 | 72290 | 0.040 |
Why?
|
| Drug Implants | 1 | 2018 | 244 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 3023 | 0.040 |
Why?
|
| Placebos | 1 | 2021 | 1676 | 0.040 |
Why?
|
| Binding Sites | 4 | 2002 | 6114 | 0.040 |
Why?
|
| Chromatin | 1 | 2008 | 2934 | 0.040 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2000 | 547 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11725 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2006 | 1922 | 0.030 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 9648 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2009 | 2788 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2017 | 63114 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 687 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2018 | 177 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 794 | 0.030 |
Why?
|
| Hemothorax | 1 | 2015 | 60 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3647 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9438 | 0.030 |
Why?
|
| Genome, Human | 1 | 2008 | 4420 | 0.030 |
Why?
|
| Hypotension | 1 | 2021 | 884 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 867 | 0.030 |
Why?
|
| Incidence | 3 | 2021 | 20947 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1994 | 156 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10481 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1994 | 518 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1906 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 264 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1387 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1504 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19229 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1994 | 596 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 691 | 0.030 |
Why?
|
| Mice | 9 | 2020 | 81183 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 29063 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2005 | 5007 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12959 | 0.030 |
Why?
|
| Inpatients | 1 | 2023 | 2518 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 733 | 0.020 |
Why?
|
| Transposases | 2 | 2002 | 107 | 0.020 |
Why?
|
| Kinetics | 2 | 2013 | 6473 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2015 | 5317 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 546 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1676 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1678 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9313 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1905 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2011 | 390 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39050 | 0.020 |
Why?
|
| Protein Conformation | 3 | 2002 | 4011 | 0.020 |
Why?
|
| Base Sequence | 3 | 2010 | 12797 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 528 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2268 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Dimerization | 2 | 2001 | 893 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2008 | 115 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3846 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 1014 | 0.020 |
Why?
|
| Chest Pain | 1 | 2015 | 1114 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2690 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2008 | 182 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4320 | 0.020 |
Why?
|
| Dyspnea | 1 | 2015 | 1303 | 0.020 |
Why?
|
| Thrombosis | 1 | 2021 | 2968 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2002 | 1801 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 970 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 6622 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 18111 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2838 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 748 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 3966 | 0.020 |
Why?
|
| Syncope | 1 | 2009 | 429 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5217 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 1106 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1751 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 893 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2478 | 0.020 |
Why?
|
| Logistic Models | 2 | 2011 | 13408 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 1184 | 0.020 |
Why?
|
| Models, Biological | 2 | 2013 | 9583 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 1623 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2715 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 3922 | 0.010 |
Why?
|
| Computational Biology | 2 | 2008 | 3521 | 0.010 |
Why?
|
| Triage | 1 | 2011 | 976 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11483 | 0.010 |
Why?
|
| DNA, Intergenic | 1 | 2003 | 107 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 68 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5892 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 281 | 0.010 |
Why?
|
| Cell Line | 3 | 2003 | 15997 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2002 | 354 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3508 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4217 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9849 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2002 | 708 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 4644 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12788 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Trypsin | 1 | 2001 | 511 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3479 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4776 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 95 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2003 | 572 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7149 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4740 | 0.010 |
Why?
|
| Titrimetry | 1 | 1999 | 36 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 1266 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2009 | 1470 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2002 | 4217 | 0.010 |
Why?
|
| Mutation | 2 | 2000 | 29786 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2307 | 0.010 |
Why?
|
| Histones | 1 | 2008 | 2599 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4931 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2073 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 13815 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1157 | 0.010 |
Why?
|
| Catalysis | 1 | 1999 | 761 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 698 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9727 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12245 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5867 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1202 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12026 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1723 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 2617 | 0.010 |
Why?
|
| Zinc | 1 | 1999 | 684 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1791 | 0.010 |
Why?
|
| United States | 2 | 2014 | 69872 | 0.010 |
Why?
|
| Registries | 1 | 2009 | 8089 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3494 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2969 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9386 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3772 | 0.010 |
Why?
|
| Software | 1 | 2003 | 4443 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 5102 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 40561 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10180 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5853 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 13881 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 35136 | 0.000 |
Why?
|